In summary, ECM1, ATF5, and EOMES may all serve as novel TSGs that are aberrantly hypermethylated at their promoters leading to their downregulated transcription, which results in HCC tumorigenesis and progression. This evidence concerns the gene ATF5 and hepatocellular carcinoma.